Tandy J Miller

Summary

Affiliation: Yale University
Country: USA

Publications

  1. ncbi request reprint Prospective observations of emerging psychosis
    Joanna Lifshey Rosen
    Prevention through Risk Identification, Management, and Education PRIME Clinic, Department of Psychiatry, Yale University School of Medicine, Yale Psychiatric Research at Congress Place, 301 Cedar Street, New Haven, Connecticut 06519, USA
    J Nerv Ment Dis 190:133-41. 2002
  2. ncbi request reprint Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability
    Tandy J Miller
    Yale University, New Haven, CT, USA
    Schizophr Bull 29:703-15. 2003
  3. ncbi request reprint Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity
    Tandy J Miller
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA
    Am J Psychiatry 159:863-5. 2002
  4. doi request reprint Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study
    Scott W Woods
    Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA
    Br J Psychiatry Suppl 51:s96-101. 2007
  5. doi request reprint Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
    Scott W Woods
    Yale University School of Medicine, New Haven, CT, USA Connecticut Mental Health Center, 34 Park Street, New Haven, CT, USA Electronic address
    Eur Neuropsychopharmacol 23:931-40. 2013
  6. ncbi request reprint Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
    Scott W Woods
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 54:453-64. 2003
  7. ncbi request reprint Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome
    Joanna L Rosen
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520 8098, USA
    Schizophr Res 85:124-31. 2006
  8. ncbi request reprint Treatment histories of patients with a syndrome putatively prodromal to schizophrenia
    Adrian Preda
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Psychiatr Serv 53:342-4. 2002

Detail Information

Publications8

  1. ncbi request reprint Prospective observations of emerging psychosis
    Joanna Lifshey Rosen
    Prevention through Risk Identification, Management, and Education PRIME Clinic, Department of Psychiatry, Yale University School of Medicine, Yale Psychiatric Research at Congress Place, 301 Cedar Street, New Haven, Connecticut 06519, USA
    J Nerv Ment Dis 190:133-41. 2002
    ..Discussion focuses on the dimensional quality of the transition both from the prodrome to psychosis and from psychosis to recovery...
  2. ncbi request reprint Prodromal assessment with the structured interview for prodromal syndromes and the scale of prodromal symptoms: predictive validity, interrater reliability, and training to reliability
    Tandy J Miller
    Yale University, New Haven, CT, USA
    Schizophr Bull 29:703-15. 2003
    ..It also presents data suggesting that excellent interrater reliability can be established for diagnosis in a day-and-a-half-long training workshop...
  3. ncbi request reprint Prospective diagnosis of the initial prodrome for schizophrenia based on the Structured Interview for Prodromal Syndromes: preliminary evidence of interrater reliability and predictive validity
    Tandy J Miller
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520, USA
    Am J Psychiatry 159:863-5. 2002
    ....
  4. doi request reprint Aripiprazole in the treatment of the psychosis prodrome: an open-label pilot study
    Scott W Woods
    Yale University School of Medicine, 34 Park Street, New Haven, CT 06519, USA
    Br J Psychiatry Suppl 51:s96-101. 2007
    ..Research studies for the treatment of the putative prodromal phase of psychotic disorders have begun to appear...
  5. doi request reprint Glycine treatment of the risk syndrome for psychosis: Report of two pilot studies
    Scott W Woods
    Yale University School of Medicine, New Haven, CT, USA Connecticut Mental Health Center, 34 Park Street, New Haven, CT, USA Electronic address
    Eur Neuropsychopharmacol 23:931-40. 2013
    ..Further studies of agents that facilitate NMDA receptor function in risk syndrome patients are supported by these preliminary findings. ..
  6. ncbi request reprint Randomized trial of olanzapine versus placebo in the symptomatic acute treatment of the schizophrenic prodrome
    Scott W Woods
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06519, USA
    Biol Psychiatry 54:453-64. 2003
    ..The prodromal phase of schizophrenic disorders has been described prospectively. The present study aimed to determine the short-term efficacy and safety of olanzapine treatment of prodromal symptoms compared with placebo...
  7. ncbi request reprint Comorbid diagnoses in patients meeting criteria for the schizophrenia prodrome
    Joanna L Rosen
    Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06520 8098, USA
    Schizophr Res 85:124-31. 2006
    ..These findings lay the groundwork for further examination of the role that comorbid conditions play in the development, course, and severity of schizophrenia...
  8. ncbi request reprint Treatment histories of patients with a syndrome putatively prodromal to schizophrenia
    Adrian Preda
    Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut 06520, USA
    Psychiatr Serv 53:342-4. 2002
    ..These data suggest that patients who present with a syndrome putatively prodromal to schizophrenia constitute a clinical population. Research into treatment interventions is indicated...